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After infection with the neurotropic CAMIRBH measles virus (MV) strain, newborn Lewis rats succumb to 
an acute necrotizing encephalopathy. Passive transfer of neutralizing monoclonal antibodies directed against 
MV hemagglutinin prevented this disease process. lnstead, either an antibody-induced acute or subacute 
measles encephalitis developed after a prolonged incubation period with a restricted expression of MV 
structural proteins. The molecular biological analysis of MV gene expression in brain tissue of rats treated witb 
MV -neutralizing antibodies revealed a transcriptional restriction of viral mRNAs, particularly for the envelope 
proteins, leading to a steep expression gradient. Based on in situ hybridization, it was concluded that the 
efficiency of transcription of viral genes at tbe single-celllevel is reduced compared with that of controls. Passive 
immunization witb monoclonal antibodies directed against otber MV structural proteins proved to be 
ineft'ective. Similar results were obtained in MV -infected weanling Brown Norway rats. These rats developed 
a clinically silent encephalitis in the presence of high titers of neutralizing antibodies. In such animals, a 
pronounced attenuation of the viral gene transcription was observed. These findings indicated that neutralizing 
antibodies directed against a restricted set of specific antigenic sites on the viral hemagglutinin protein 
expressed on cell membranes exert a modulating efl'ect on the viral gene expression at the Ievel of transcription. 
This phenomenon contributes to the switch from the acute cytopathic eft'ect to a persistent infection in the 
central nervous system. 
Persistent measles virus (MV) infections of the centrat 
nervous system (CNS) are associated with subacute or 
chronic disease processes (14, 22). In humans, subacute 
sclerosing panencephalitis and measles inclusion body en-
cephalitis develop as rare complications months to years 
after the onset of acute measles. In these two diseases, the 
MV infection has been characterized and it can be shown 
that a restriction of MV gene expression enables the virus to 
persist (2, 3, 8, 9, 16). However, no information is available 
about factors contributing to the establishment and initial 
maintenance of a persistent MV infection in the CNS. So far, 
only in vitro studies have been done with tissue culture cells 
of neural or nonneural origin to characterize the events 
which Iead to persistence (18, 25). These experiments sug-
gest that possible determinants reside in specific virus-host 
cell interactions govemed by highly specialized target cells 
and their stage of differentiation. Moreover, it was found 
that antibodies interacting with MV glycoproteins expressed 
on infected cell membranes may initiate and support the 
establishment of a persistent infection by interference with 
the productive replication of the viral genome and an alter-
ation of the synthesis of MV structural proteins (4, 11, 12). 
This phenomenon has been called antibody-induced anti-
genic modulation. 
A suitable model to analyze these factors is provided by 
inbred rats with a MV infection of the CNS. In this model, 
infected newborn Lewis and Brown Norway (BN) rats die 
from a necrotizing encephalopathy (NE), whereas weanling 
Lewis rats develop inftammatory CNS disease processes in 
the form of either an acute encephalitis (AE) or a subacute 
measles encephalitis (SAME). In contrast, infected weanling 
BN rats do not develop clinical signs, although a subacute 
encephalitis (clinically silent encephalitis [CSE]) can be 
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documented histopathologically (17). The basis for the de-
velopment of SAME and CSE is a persistent MV infection 
without production of infectious virus in brain tissue. This 
defective replication is characterized by restricted synthesis 
of MV envelope proteins in infected brain cells which starts 
in rats with AE (17). Furthermore, in Lewis rats with 
SAME, an attenuation of the transcription of MV envelope 
genes and translational defects for the matrix (M)-specific 
mRNA (21) have been observed which resemble the Situa-
tion in subacute sclerosing panencephalitis and measles 
inclusion body encephalitis (2, 3, 8, 9, 16). 
In the present study, the effect of antiviral antiborlies on 
the course of experimental MV infection of brain tissue in 
rats was analyzed. Passive transfer of neutralizing monoclo-
nal antiborlies directed against the MV hemagglutinin (H) to 
infected newborn Lewis and BN rats was found to prevent 
the occurrence of the NE. lnstead, antibody-induced AE 
(AI-AE) and Al-SAME developed after prolonged incuba-
tion periods. Both disease types revealed a pronounced 
restriction of MV gene expression in comparison with con-
trol animals. In weanling BN rats, a similar effect on MV 
replication was observed, probably as the result of the 
naturally occurring humoral hyperimmune response devel-
oping against the viral infection in such rats. These experi-
ments indicated that MV antibodies interfere with MV gene 
expression and support the establishment of virus persis-
tence in brain tissue. 
MATERIALS AND METHODS 
Animals and inoculation. Pregnant SPF rats of the Lewis 
and BN inbred strains were obtained from the Zentralinstitut 
für Versuchstiere, Hannover, Federal Republic ofGermany. 
Newbom or weanling (3 to 4 weeks old) rats were infected 
by intracerebral inoculation with 104 50% tissue culture 
infective doses in 25 J.Ll of our neurotropic CAMIRBH strain 
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of MV, a derivative of the CAM R/40 strain which we 
originally obtained from K. Yamanouchi, Measles Institute, 
Tokyo, Japan (15, 17). Newborn rats were injected intraper-
itoneally with monoclonal antiborlies directed against mea-
sles structural proteins (50 to 250 J.Ll of antibody-containing 
ascites) 5 to 8 h after infection. In weanling rats, no attempts 
were made to interfere with the natural course of the CNS 
infection by passive transfer of antiviral antibodies. 
Antibodies. The monoclonal antiborlies used in this study 
are directed against the following structural proteins of MV: 
the nucleocapsid (N) protein (antibodies F227 and L396), the 
phospho (P) protein (16AF10, a kind gift from E. Norrby, 
Karolinska Institutet, Stockholm, Sweden [19]), the matrix 
(M) protein (F266, K121, B117), the fusion (F) protein 
(A351, A352, A5048), and the H protein (L77, K17, NC32; 
referred to in this report as H1 to H3). The antigen specificity 
of these antiborlies was tested by radioimmunoprecipitation 
of e5S]methionine-labeled MV-infected Vero celllysates (6, 
7). All antiborlies are of the immunoglobulin G (IgG) isotype 
(lgG1, IgG2a, IgG3) except L396, which is an IgM antibody. 
The anti-H antiborlies used neutralize infectious MV. Ap-
proximately 5,000 neutralizing units (NU) (as 0.15 to 0.3 mg 
of immunoglobulin as determined after protein A column 
purification) were injected into each rat. One NU was 
defined as the concentration of antibody that neutralizes 50% 
of 100 PFU. The nonneutralizing N-, P-, M-, and F-specific 
antiborlies were used at a concentration of 0.25 mg of 
immunoglobulin. As a control, we used a monoclonal anti-
body directed against the E2-spike glycoprotein of JHM 
coronavirus that was kindly provided by Helmut Wege, 
Institut für Virologie und Immunbiologie, Universität 
Würzburg. 
Determination of antiviral humoral immune response. 
Paired samples of serum and cerebrospinal fluid (CSF) of 
rats ofboth inbred strains with histologically verified AE and 
SAME and CSE, respectively, were analyzed by an enzyme-
linked immunoassay as described previously (17). The titer 
of neutralizing antiborlies was determined by a neutralization 
assay. Briefty, 100 PFU ofthe Edmonston strain ofMV were 
incubated at 37°C for 1 h with serial dilutions of rat serum or 
CSF. Subsequently, these mixtures were seeded in quadru-
plicate on just conftuent monolayers of Vero cells in micro-
dilution plates. The occurrence of the viral cytopathic effect 
was monitored after 4 days, and the neutralization titerwas 
determined by standard procedures. 
Virus isolation. A modification of a previously published 
procedure was used for virus isolation (17). Briefty, MV was 
reisolated from brain tissue of infected animals by incubation 
of diluted brain homogenate (Dounce homogenized and 
clarified by centrifugation) on monolayers ofVero cells, and 
the titer of the isolated viruswas determined. 
Histology and immunohistology. Brain and spinal cord 
were fixed in buffered paraformaldehyde, and sections were 
cut from paraffin blocks and stained with hematoxylin. The 
in vivo expression of MV structural proteins in the CNS was 
analyzed on snap-frozen brain material by using indirect 
immunoftuorescence as described previously (16). As the 
first reagent, pooled monoclonal antibodies against the indi-
vidual proteins were used in the appropriate dilution fol-
lowed by incubation with a ftuorescein isothiocyanate con-
jugate directed against the F(ab'h fragment of mouse IgG. 
On serial acetone-fixed sections, the number of cells ex-
pressing the individual MV proteins was determined and the 
frequency was expressed relative to the cells labeled with 
the N-specific antibodies. Cells efficiently synthesizing the 
MV N protein were defined as infected. 
Extraction of RNA and Northern (RNA) blot experiments. 
RNA was extracted from snap-frozen brain material as 
described previously (21). Briefty, brain material was ho-
mogenized in guanidinium isothiocyanate buffer, and RNA 
was purified by centrifugation through a CsCI cushion (1. 7 
g/cm3). Polyadenylated RNA was purified by one cycle of 
oligo(dT) selection, separated on a 1.5% agarose gel contain-
ing formaldehyde, and transferred to nitrocellulose filters. 
Hybridization was performed with strand-specific [32P]CTP-
labeled RNA probes transcribed in vitro from Gem-1-cloned 
MV-specific cDNAs for the following genes: 851-base-pair 
(bp) EcoRV-Xbai fragment of the N gene, 531-bp Baß-
Hindiii fragment of the P gene, 526-bp Bgßii-EcoRI frag-
ment of the M gene, 320-bp Taqi-Ddei fragment of the F 
gene, and 787-bp Bgßii-Avai fragment of the H gene. The 
cDNA clones were kindly provided by M. A. Billeter, 
Institut für Molekularbiologie II, Universität Zürich, and 
were described previously (8). To each RNA sample ana-
lyzed, 2 fmol of a mixture of standard RNA transcripts was 
added before electrophoresis. Standard RNAs were synthe-
sized in vitro from the cDNA clones described above in 
opposite orientation to the hybridization probes and there-
fore migrated corresponding to the length of the individual 
cDNA. After autoradiography, bands for the standard RNA 
transcripts and the monocistronic MV-specific mRNAs were 
excised from the nitrocellulose filters and the radioactivity 
retained was determined by scintillation counting. 
In situ hybridization. In situ hybridization was performed 
as described previously with slight modifications (21). 
Briefty, paraffin-embedded tissues were cut in 5- to 8-J.Lrn-
thick sections and applied to pretreated slides. Sections were 
deparaffinized and deproteinized. MV -specific cDNA clones 
described above were transcribed in vitro in the presence of 
[35S]UTP and hybridized to the brain sections at 48°C for 16 
h. After hybridization, slides were washed in three changes 
of HWM (50% formamide, 0.6 M NaCl, 20 mM Tris hydro-
chloride [pH 7.2], 2 mM EDTA) at 48 to 50°C for 45 min. 
After dehydration, slides were immersed in Kodak NTB2 
emulsion, exposed for 4 days at 4°C, developed in 019 
developer (Kodak), fixed in 30% sodium thiosulfate, and 
counterstained with either hematoxylin and eosin or Giemsa 
stain. 
RESULTS 
Antibody ell'ect on course of MV encephalitis. Newbom 
Lewis and BN rats succumb to infection with the neurotro-
pic MV within 5 to 6 days. The histological changes are of a 
degenerative and necrotic type without accompanying cellu-
lar infiltrates, revealing an acute NE. Weanling Lewis rats (3 
to 4 weeks old) developed AE and SAME. The latter is 
characterized by dense perivascular infiltration with lymph-
omonocytic cells in the grey and white matter of the CNS 
with little involvement of the parenchyma. In contrast, the 
salient features of the AE are scant disseminated lymph-
omonocytic cell infiltration of the parenchyma with neu-
ronophagia and glial nodules. The large majority of infected 
weanling BN rats does not develop a clinical disease, but in 
infected animals, a subacute CSE can be documented histo-
pathologically, with gliosis and plasma cell infiltration in 
brain tissue and perivascular spaces (17). Monoclonal anti-
hodies directed against the different structural proteins of 
MV were tested for their ability to protect the newbom 
Lewis rats from the acute fatal NE (Table 1). None of the 
nonneutralizing antiborlies (directed against N, P, M, and F) 
at any dose (up to 2 mg of purified immunoglobulin) given 
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T ABLE 1. In vivo effect of virus-specific monoclonal antibodies 
on the course of experimental measles encephalitis in Lewis rats 
Treatment No. of lncubation Neuro- lncidence Virus 
with animals period pathology (%) isolation 
antibody0 infected (days) (log PFU)b 
Controlc 8 5-6 NE 100 4.5 
Anti-N 12 5-7 NE 100 4.1 
Anti-P 4 6-7 NE 100 5.0 
An ti-M 12 5-7 NE 100 4.7 
Anti-F 20 5-10 NE 100 4.2 
Anti-H1 10 8-12 AI-AE 63 2.1 
18-27 Al-SAME 27 0 
Anti-H2 5 11-16 AI-AE 80 2.9 
36 AI-SAME 20 0 
Anti-H3 8 8-13 AI-AE 75 1.7 
27-31 Al-SAME 25 0 
a A 250-~.~-g portion of purified immunoglobulin of the control or individual 
anti-N, -P, -M, and -F antibodies or 5,000 NU ofthe anti-H antibody (150 to 
300 1.1-8) was injected into each animal. Groups of six animals received anti-N 
antibody F227 or L396 or anti-F antibody A352 or A5084; groups offour rats 
were treated with anti-M antibody F266 or K121 or 8117; and eight rats were 
injected with the anti-F A351 antibody. 
b Mean titer per gram of brain weight. 
c lncludes four untreated animals and four animals treated with a mouse 
monoclonal antibody directed against JHM coronavirus. 
either as mixtures or as individual monoclonal antibodies 
had an effect on the clinical course of the disease except for 
a slight prolongation of the incubation period in anti-F-
treated rats. Titers of MV isolated from brain tissue homoge-
nate were in the same range as in animals that were passively 
immunized with a monoclonal antibody to JHM coronavirus 
(Table 1). The histological examination revealed no signifi-
cant differences in the pattem and distribution of the neuro-
pathologicallesions in these animals. In contrast, the mono-
etonal antibodies against MV H prevented the development 
of the NE in infected animals. The passive transfer of more 
than 10,000 NU (approximately 0.5 mg of immunoglobulin) 
resulted in an increasing percentage of animals in which no 
evidence for viral replication in the brain tissue could be 
obtained, and less than 500 NU were ineffective. A dose of 
5,000 NU prevented the NE but allowed viral replication in 
almost all animals. This dosewas therefore used for further 
experiments reported in this study. 
Mter passive transfer of anti-H antibodies, 74% of MV-
infected newbom Lewis rats (17 of 23) developed an AI-AE 
after an incubation period of 8 to 15 days and 26% (6 of 23) 
developed an AI-SAME after incubation periods of 3 to 5 
weeks. The histological changes observed in these rats were 
similar to those described for AE and SAME in weanling 
Lewis rats (17). Thus, AI-AE is characterized by neurono-
phagia and glial nodules, while the lesions in AI-SAME 
consisted mainly of lymphocytic infiltrations, predominantly 
located perivascularly in the white matter. The effect on the 
disease course of antibody treatment of newbom BN rats 
was essentially identical (data not shown). Only the anti-H 
antiborlies protected the newbom rats from the fatal enceph-
alopathy. Histopathologically, an AI-CSE was verified in 
40% of the infected BN rats afterpassive transfer of 5,000 
NU of anti-H antibodies. 
Expression of viral proteins in brain tissue in vivo. Measles 
antigen was rletected in the brain sections of all animals 
J. VIROL. 
TABLE 2. Expression of MV structural proteins 
in infected brain cells 
Antibody No. of Disease Structural protein (%)
0 
animals treatment 
studied type N p M F 
Nonneutralizing 
antibodies 
Anti-JHM 4 NE 100 93 36 35 
Anti-N 6 NE 100 98 33 26 
Anti-P 4 NE 100 93 38 30 
An ti-M 5 NE 100 97 42 26 
Anti-F 9 NE 100 96 31 25 
Neutralizing 
antibodies 
Anti-H1 to H3 8 AI-AE 100 91 28 21 
Anti-H1 to H3 7 Al-SAME 100 89 2 4.5 
H 
33 
30 
32 
34 
29 
12 
1 
a Mean expression of MV structural proteins calculated in relation to N 
protein-expressing cells. 
examinerl regardless of the antiborlies transferred (Table 2). 
In animals treated with virus-specific nonneutralizing anti-
bodies, the viral P protein was present in 93 to 98% of the 
infecterl cells, whereas the envelope proteins were detected 
at a lower percentage: the M protein in 31 to 42%, the F 
protein in 25 to 35%, and the H protein in 29 to 34% of the 
infecterl cells. In animals treated by passive transfer of 
neutralizing antiborlies directed against the H protein, how-
ever, an attentuation ofthe envelope protein expressionwas 
observed. Already after a short incubation periorl (8 to 13 
days), a restriction of envelope protein synthesis coulrl be 
seen which was amplifierl in animals that developed AI-
SAME with a survival period of 3 and more weeks. 
Expression of MV -specific transcripts in brain material. To 
examine the expression of virus-specific mRNAs in brain 
material from antiborly-treated anrl untreated control ani-
mals, polyadenylated RNA was extracted from the brains of 
MV-infected animals and subjecterl to Northern blotting. In 
Fig. 1, typical expression patterns for MV transcription in 
brain material from untreated control animals (Fig. lA), anti-
N-treated animals (Fig. 1B), and anti-F-treated animals (Fig. 
1C) are shown. The pattern of hybridization was similar in 
these animals, and signals for all MV-specific monocistronic 
polyadenylated transcripts {N, P, M, F, and H) could be 
seen as weil as signals for bicistronic and polycistronic 
transcripts. The same results were obtained when infected 
animals were treated with anti-M antibodies (data not 
shown). However, the Northern blots obtained for +pA 
RNA derived from the brains of animals treated with anti-H 
antiborlies were different, revealing a generally restricted 
transcriptional efficiency and a reduced expression of MV-
specific F anrl H transcripts (Fig. lD). 
To quantify the expression of MV -specific transcripts in 
brain material seen in the Northern blots, the bands corre-
sponding to the moncistronic mRNAs were excised and the 
individual copy number per 10 pg ofRNA was determined in 
relation to the standard RN A transcripts added before elec-
trophoresis. In addition, the absolute expression rates were 
determined as relative expression values in relation to the 
signal obtained for the corresponding N mRNA (100% 
expression) (Table 3). No significant differences in the tran-
scription pattern were found between control animals and 
those treated with nonneutralizing antibodies (anti-N, anti-
M, and anti-F). An almost identical expression gradient 
could be seen according to the gene order which is similar to 
the one observed previously in weanling rats (21). 
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FIG. 1. Northem blot analysis of 2 J.L8 of each +pA RNA derived from brain material of newbom Lewis rats with NE (A to C) and 
AI-SAME (D). (A) Untreated animal (5 days p.i.); (B) anti-N-treated animal (6 days p.i.); (C) anti-F-treated animal (8 days p.i.); (D) 
anti-H-treated animal (36 days p.i.). RNAs were hybridized as described in the text to RNA probes specific for the N gene (lanes 1), the P 
gene (lanes 2), the M gene (lanes 3), the F gene (lanes 4), and the H gene (lanes 5). Symbols: t>, position of the polycistronic polyadenylated 
RNAs; ..,., position ofthe monocistronic polyadenylated RNAs; 0, position ofthe standard RNA transcripts migrating according to the length 
of the individual probe. Total amounts of the standard RNAs were 2 fmol, except in panel D, lane 5, where only 1 fmol of the H standard 
was applied. In panel B, an artifact due to the transfer procedures is visible at the position of the polycistronic RNAs of M, F, and H. 
A significantly different effect on MV transcription was 
achieved in animals treated with neutralizing anti-H antibod-
ies. Both groups of animals with either AI-AE or AI-SAME 
revealed a restriction of MV gene expression. The data 
obtained on transcriptional efficiencies for MV -specific 
mRNAs did not show significant differences for animals with 
AI-AE (10 to 14 days postinfection [p.i.]) and animals with 
AI-SAME with Ionger incubation periods (27 and 36 days 
p.i.). The intensity of the hybridization signals of the N 
mRNA was reduced to about 40 to 57% in comparison with 
the control animals, and the transcription ofP, M, F, and H 
geneswas drastically restricted. The expression ofP, M, and 
F mRNAs ofthese two groups treated with anti-H antibodies 
was reduced 47 to 44, 26 to 20, and 10 to 6%, respectively. 
The H mRN A was not detectable in four of the five experi-
ments. Similar results were obtained in experiments with 
newbom BN rats with the same set of monoclonal antibodies 
(data not shown). In vitro translation experiments performed 
with polyadenylated RNA from brain material of animals 
with antibody-induced encephalitis confirmed these results 
since only N- and P-specific translation products could be 
detected (data not shown). Because of the low copy number 
ofthe mRNA forM protein, we could not determine whether 
there are additional translational defects, as shown for 
SAME in weanling Lewis rats (21). 
In situ hybridization. In situ hybridization experiments 
were performed on brain sections from animals with Al-
SAME to gain more information on the observed restricted 
transcription. Brain sections of animals treated with the 
neutralizing anti-H antibodies were hybridized with the same 
strand-specific RNA probes as for the Northem blot exper-
iments. Since the age and the maturation of the developing 
brain may inftuence MV gene expression in brain cells, 
sections from age-matched treated and untreated animals 
TABLE 3. Quantitativeanalysis of MV-specific gene expression in brains of antibody-treated and control Lewis rats 
CNS disease Incubation No. of copies (%) of MY·specific mRNA
0 
Anima! group (no. of rats) period (days p.i.) N p M F H 
Untreated control animals NE (4) 5-7 3,600 (100) 2,100 (58.3) 1,600 (44.4) 600 (17.0) 350 (9.7) 
N onneutralizing antibodies 
Anti-N NE (4) 5-7 4,600 (100) 3,100 (67.4) 2,200 (47 .8) 1,000 (21. 7) 510 (11.1) 
An ti-M NE (4) 5-7 5,500 (100) 3,200 (58.2) 2,500 (45.4) 1,200 (21.8) 720 (13.1) 
Anti-F NE (5) 5-8 4,000 (100) 2,450 (61.3) 1,820 (45.5) 840 (21.0) 480 (12.) 
Neutralizing anti-H AI-AE (3) 10, 12, 14 1,900 (100) 900 (47.3) 500 (26.3) 200 (10.5) NDb 
antibodies AI-SAME (2) 27, 36 2,050 (100) 900 (44.0) 400 (19.5) 130 (6.3) (50) (2.4)'" 
a The absolute number of the individual transcripts was determined as copies per 10 pg of RNA (copies), and the relative expression rates in relation to the 
expression of the corresponding N mRNA (N = 100%) are given as mean percent values foreachexperimental group. 
b ND, No signal detectable. 
" In one animal, 50 copies of H mRNA were detected; the other animal did not show an H-specific signal. 
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T ABLE 4. Antiviral humoral immune response in weanling 
Lewis and BN rats 
Disease 
type 
AE 
AE 
SAME 
CSE 
AE 
AE 
SAME 
CSE 
Strain 
Lewis 
BN 
Lewis 
BN 
Lewis 
BN 
Lewis 
BN 
No. of 
animals 
analyzed 
16 
13 
12 
15 
16 
13 
12 
15 
Antibody titer" (mean [range]) 
EIA NT 
Serum Serum 
<25 (NAb) <10 (NA) 
<25 (NA) <10 (NA) 
400 ( <25-1,600) 20 (<10-80) 
1,600 (200-6,400) 320 (80-640) 
CSF CSF 
<25 (NA) <10 (NA) 
<25 (NA) <10 (NA) 
50 (<25-100) <10 (<10-10) 
200 (50-800) 40 (10-80) 
o Reciprocal of endpoint dilutions of MV -specific antibodies in enzyme 
immunoassay (EIA) and neutralization test (NT). Serum and CSF samples 
were obtained from the same group of animals. 
b NA, Not applicable. 
were used in parallel. Hybridization with the N gene-specific 
probe revealed no significant difference in the number of 
infected cells between the two groups of animals (Fig. 2A 
and B). This finding was confirmed by using the hybridiza-
tion probe of the opposite sense detecting the negative-
strand genomic RNA (data not shown). The hybridization 
signal in the infected brain cells of the antibody-treated 
animals, however, revealed a much lower intensity for the N 
mRNA as evident at higher magnification (Fig. 2C and D). 
Thus, the overall restriction of MV gene expression obvi-
ously results from restricted MV gene expression in the 
majority of infected cells rather than from a reduced number 
of infected cells. The number of cells showing a positive 
signal for the P mRN A was almost identical to the number of 
N mRNA-expressing cells, whereas M, F, and H mRNA-
positive cells were barely visible in the antibody-modulated 
animals (data not shown). 
Efl'ect of naturally occurring antiviral humoral immune 
response on expression of viral transcripts in brain tissue. The 
phenomenon of antibody-induced restriction of MV gene 
expression in newbom rats depends on passive transfer of 
virus-specific monoclonal antibodies. Todetermine whether 
antiborlies developing during MV infection in older animals 
inftuence viral replication, we included MV-infected wean-
ling Lewis and BN rats with different types of encephalitis in 
our study. Rats with AE did not reveal viral antiborlies in 
sera and CSF (Table 4), whereas those with SAME or CSE 
developed an MV -specific humoral immune response that 
was not detectable at incubation periods when AE occurred 
in other animals (data not shown). In particular, BN rats 
with CSE developed high titers of MV -specific neutralizing 
antibodies. The antibody titers were significantly lower in 
Lewis rats with SAME (P > 99.5%, Mann-Whitney U test). 
The expression gradient obtained by Northem blot anal-
ysis for MV -specific transcripts in weanling BN rats with AE 
was almost identical to that of Lewis rats with AE, and no 
differences were observed either in the overall expression 
rate of viral transcription or in the slope of the gradient 
(Table 5). Northem blot analysis of RNA derived from BN 
rats with CSE, however, revealed differences. Whereas in 
Lewis rats with SAME the transcriptional efficiency of the 
MV genes was similar to the rate in rats with AE (Fig. 3A), 
the expression gradient of the viral mRNAs in BN rats with 
CSE was significantly steeper (Fig. 3B). The signal intensity 
for the P-, M-, and F-specific mRNAs was drastically 
decreased, and a signal specific for the H-specific mRNA 
was not detectable. This expression gradient was confirmed 
in five individual animals analyzed. By quantification of the 
signals obtained from BN rats with CSE, an overall reduc-
tion of the expression of the N gene by 65% compared with 
the Lewis rats with SAME was apparent (Table 5). The 
mean values for the expression ofindividual mRNAs relative 
to the N gene revealed a decrease in transcription of the P 
mRNA to 34.5% in animals with CSE (46% in rats with 
SAME), of the M mRNA to 15% (36% in rats with SAME), 
and of the F mRNA to 4.5% (12% in rats with SAME). 
H-specific mRNA was not detected in four of the five 
animals with CSE that were analyzed. 
DISCUSSION 
The infection of newbom Lewis rats with the neurotropic 
CAMIRBH strain of MV invariably Ieads to a fatal acute NE. 
By administration of neutralizing anti-H antiborlies after the 
infection, this CNS disease process can be prevented. In-
stead, AI-AE or AI-SAME develops after prolonged incu-
bation periods which are characterized by a transcriptional 
restriction of viral gene expression. This phenomenon does 
not occur when nonneutralizing antiborlies are passively 
transferred. On the Ievel of mRNA synthesis, the P and 
envelope genes are affected. While the reduced amount of P 
mRNA still directs the synthesis of sufficient protein to be 
demonstrated in almost all infected cells, the envelope 
proteins are not synthesized in detectable concentrations in 
the large majority of infected cells. This is accompanied by 
the failure to rescue infectious virus from the brains of 
animals with AI-SAME. 
The same modulation of the CNS disease process with 
reduced efficiency of MV gene transcription occurs naturally 
in weanling BN rats. Theserats develop CSE in association 
with high titers of virus-specific antibodies. 
In our model, the development of a clinically overt CNS 
disease process seems to be linked to a low or absent 
humoral immune response against MV as seen in SAME or 
AE in Lewis rats (10). In contrast, the development of CSE 
in BN rats is correlated with high titers of MV -specific 
antiborlies in serum and CSF and lower Ievels of virus 
replication compared with those in Lewis rats (17). Similar 
observations were made for MV or coronavirus infections in 
mice (5, 20). lt was found that the administration of virus-
specific antiborlies can result in the emergence of chronic 
progressive CNS diseases or an atypical neuropathological 
response. Moreover, in mumps virus-induced meningoen-
cephalitis in hamsters, a differentiated etfect of the glycopro-
tein-specific antiborlies on the course of the disease has been 
reported. N eutralizing hemagglutinin/neuraminidase-specific 
antiborlies protected the animals from disease, while non-
neutralizing Fantibodies were ineffective (24). A correlation 
between an antiviral immune response and viral gene expres-
sion similar to our findings in the CNS of MV-infected rats 
FIG. 2. In situ hybridization ofparaffin-embedded brain sections with the [35S]UTP-Iabeled N mRNA-specific RNA probe. (A) Weanling 
Lewis rat with AE (30 days old, 7 days p.i.); (8) newborn Lewis rat with AI-SAME (36 days p.i., anti-H); (C) detail panel of A; (D) detail 
of panel B; magnifications, x250 (A and B) and x600 (C and D). 
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TABLE 5. Quantitativeanalysis of MV-specific gene expression in brain material from weanling Lewis and BN rats" 
Rat Disease CSF antibodies No. of copies (%) of MV -specific mRNA 
strain type against MVb N p M F H 
Lewis AE 4,400 (100) 2,400 (54.5) 1,850 (42) 650 (15) 400 (8) 
BN AE 3,900 (100) 2,400 (62) 1,550 (40) 650 (16.5) 300 (8) 
Lewis SAME Low 3,850 (100) 1,770 (46) 1,390 (36) 460 (12) 180 (4.5) 
BN CSE High 1,300 (100) 450 (34.5) 250 (15) 60 (4.5) NDC 
"Summarized are the mean vaJues of the expression rates for groups of five animals each with AE (10 to 14 days p.i.), SAME (28 to 56 days p.i.), and CSE 
(30 to 60 days p.i.). 
b The anti-MV antibody titers in CSF of all specimens are shown in Table 4. 
" ND, No signal detectable. 
has been observed in a nonneurological disease. In minks 
infected with Aleutian disease virus, it was found that a 
restriction of viral replication and transcription develops in 
Jung tissue in the presence of antiviral antiborlies (1). The 
alterations on the molecular Ievel were accompanied by a 
chronic immune complex disease instead of an acute inter-
stitial pneumonia that usually follows Aleutian disease virus 
infection in the absence of virus-specific antibodies. Al-
though the specificity of the viral antiborlies applied was not 
determiried, the data show that antiviral antiborlies contrib-
ute to chronic disease processes by downregulating viral 
gene expression. 
Besides the antibody-induced restriction on MV gene 
expression in brain tissue, celhilar factors are also capable of 
inhibiting MV replication. In a recent study, we observed in 
newborn as weil as in weanling Lewis rats with CNS 
infections an MV transcriptional restriction of the glycopro-
tein-specific mRNAs as soon as MV -specific transcripts 
were detectable in brain tissue (21). This phenomenon was 
independent of the age of the animals, the incubation period 
of disease, and the humoral immune response since MV 
antiborlies were not detectable in infected newborn rats. 
These cellular factors suppress a lytic cycle of viral replica-
tion in many brain cells immediately after infection. How-
ever, alone they arenot capable ofpreventing an acute CNS 
disease since still too many brain cells are destroyed or 
functionally impaired by the infection. Only in concert with 
FIG. 3. Northem blot analysis of 1 ~g of each +pA RNA from a 
Lewis rat with SAME (A) and a BN rat with CSE (B); both animals 
were at 30 days p.i. Symbols: t>, Position of the polycistronic RNA 
transcripts; ~. position of the monocistronic RNA transcripts; 0, 
position of the standard RNA transcripts. 
antiviral antiborlies is the inhibition of MV replication in 
brain cells so effective that destruction of infected cells is 
either prevented or slowed down and an acute disease 
process avoided. This combined effect of host factors and 
antiborlies on MV replication is documented by the reduced 
overall viral transcription rate of about 50% and an enhanced 
restriction of MV envelope-specific mRNAs in animals with 
AI-SAME in comparison with untreated animals. This inter-
pretation is further supported by our in situ hybridization 
experiments. The analysis of the N gene-specific expression 
at the single-cell Ievel revealed that the observed enhanced 
restriction in antibody-treated animals does not result from a 
reduced number of infected cells but rather from a lower 
gene expression per infected cell. This finding indicates a 
generat effect of antiviral antiborlies on the viral transcrip-
tion machinery and does not suggest an elimination of 
infected brain cells by host defense mechanisms or a lytic 
MV infection. 
1t remains speculative how the intracellular effect of 
antibody-induced antigenic modulation is achieved. In tissue 
culture experiments, capping of viral surface proteins after 
the binding of the appropriate antibody has been described 
(13). These immune complexes are either intemalized or 
shed from the cell surface, leading to a temporary disappear-
ance of viral antigens. By this means, virus is able to persist 
since antibody- and complement-mediated cell Iysis cannot 
occur. However, besides removing viral glycoproteins from 
cell surfaces, ailtibodies also change the expression of some 
intracellular viral polypeptides. It was observed that appli-
cation of polyclonal antiborlies against MV or monoclonal 
antiborlies against MV H protein to infected cells led to a 
reduced amount of total MV P and M proteins (11). In 
another study, application of anti-H monoclonal antiborlies 
downregulated intracellular viral protein synthesis only 
when rat glioma cells persistently infected with MV and not 
infected Vero cells or Jung fibroblasts were used (4). These 
findings suggested that signal transmission leading to tran-
scriptional alterations of the viral genome is cell type spe-
cific. In this context, an interesting observation has been 
made recently (23). The addition of antimeasles IgG to the 
culture medium of rat glioma cells persistently infected with 
MV led to the activation of a G protein-mediated induction 
of inositol polyphosphate production. In turn, phosphoki-
nase C was activated, which could Iead to differential 
phosphorylation and affect the viral transcriptase complex 
itself. Such alterations in phosphorylation of MV M and P 
proteins, which are components necessary for the viral 
transcription and maturation process, have been described 
in the presence of antiviral antiborlies (11). Altematively, the 
activity or synthesis of cellular cofactors for viral transcrip-
tion could be altered by phosphorylation. 
At present, it is still unclear how the observed differential 
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downregulation of the viral gene transcription in the brains 
of the two rat strains is achieved. The presence of antiviral 
antibodies certainly enhances host cell-specific restriction of 
the MV gene expression, thereby preventing an acute dis-
ease process and supporting the establishment of a persistent 
infection of the CNS. Without doubt, the phenomenon of 
antigenic modulation in vivo plays a pathogenetic role in the 
development of subacute or chronic diseases. It will be 
important to unravel the molecular mechanism by which 
viral antibodies interfere with intracellular events of viral 
replication. 
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